Sign up to save your podcasts
Or
Share What are the implications of adjuvant therapy data on biomarker evaluation?
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
What are the implications of adjuvant therapy data on biomarker evaluation?
touchMDT for touchONCOLOGY
Listen to a medical oncologist and a pathologist discuss the benefits of biomarker testing in early and locally advanced NSCLC.
The multidisciplinary team
- Medical oncologist: Dr David Planchard, France
This touchPODCAST is for HCPs only.
This activity is funded by an unrestricted independent medical education grant from AstraZeneca. This activity is jointly provided by USF Health and touchIME.
For further information visit our website: https://touchoncologyime.org/evolving-role-mdt-early-nsclc/
View all episodes
By touchpodcasttouchMDT for touchONCOLOGY
Listen to a medical oncologist and a pathologist discuss the benefits of biomarker testing in early and locally advanced NSCLC.
The multidisciplinary team
- Medical oncologist: Dr David Planchard, France
This touchPODCAST is for HCPs only.
This activity is funded by an unrestricted independent medical education grant from AstraZeneca. This activity is jointly provided by USF Health and touchIME.
For further information visit our website: https://touchoncologyime.org/evolving-role-mdt-early-nsclc/